SYSTEM FOR CONTROLLING AN ADMINISTRATION OF INFUSED SUBSTANCES
A system for controlling an administration of a vasopressor agent comprising: at least one processing unit; and at least one non-transitory computer-readable memory communicatively coupled to the at least one processing unit and comprising computer-readable program instructions executable by the at least one processing unit for: receiving, by the at least one processing unit, a current arterial pressure of a patient; determining, with the at least one processing unit, based on a profile of the patient, a dose parameter to be adjusted as a function of at least the current arterial pressure and a target arterial pressure; and controlling, with the at least one processing unit, the operation of a pump administering the vasopressor agent as a function of the dose parameter; wherein the receiving, determining and controlling are performed continuously by the at least one processing unit..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 13. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LAMONTAGNE FRANÇOIS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-13, Last update posted on www.tib.eu: 2024-03-26, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
EP4333935 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA001209264 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA001209264 | ||
| 003 | DE-627 | ||
| 005 | 20240329160446.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240322s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA001209264 | ||
| 035 | |a (EPA)EP4333935 | ||
| 035 | |a (EPA)83931999 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LAMONTAGNE FRANÇOIS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SYSTEM FOR CONTROLLING AN ADMINISTRATION OF INFUSED SUBSTANCES |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-13, Last update posted on www.tib.eu: 2024-03-26, Last updated: 2024-03-29 | ||
| 520 | |a A system for controlling an administration of a vasopressor agent comprising: at least one processing unit; and at least one non-transitory computer-readable memory communicatively coupled to the at least one processing unit and comprising computer-readable program instructions executable by the at least one processing unit for: receiving, by the at least one processing unit, a current arterial pressure of a patient; determining, with the at least one processing unit, based on a profile of the patient, a dose parameter to be adjusted as a function of at least the current arterial pressure and a target arterial pressure; and controlling, with the at least one processing unit, the operation of a pump administering the vasopressor agent as a function of the dose parameter; wherein the receiving, determining and controlling are performed continuously by the at least one processing unit. | ||
| 650 | 4 | |a G16H: Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data | |
| 650 | 4 | |a A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000) | |
| 650 | 4 | |a A61M: Devices for introducing media into, or onto, the body (introducing media into or onto the bodies of animals a61d0007000000; means for inserting tampons a61f0013260000; devices for administering food or medicines orally a61j; containers for collecting, storing or administering blood or medical fluids a61j0001050000); devices for transducing body media or for taking media from the body (surgery a61b; chemical aspects of surgical articles a61l; magnetotherapy using magnetic elements placed within the body a61n0002100000); devices for producing or ending sleep or stupor | |
| 650 | 4 | |a med | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MICHAUD JEAN-BAPTISTE |4 aut | |
| 700 | 0 | |a GERVAIS ALAIN |4 aut | |
| 700 | 0 | |a CAMIRAND LEMYRE FÉLIX |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 13. März |
| 773 | 1 | 8 | |g year:2024 |g day:13 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/83931999/publication/EP4333935A1?q=EP4333935 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 13 |c 03 | ||